EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Brighthouse Financial, Inc.
BHF

BHF Brighthouse Financial, Inc.

Brighthouse Financial, Inc. · NASDAQ
Market Closed
50.11
▼ ⁦-1.44%⁩ (-0.73)
Market Cap$2.9B
Beta0.86
52w Low52w High
42.0766.80
Last Week
⁦-6.55%⁩
Last Month
⁦-16.61%⁩
Last 3 Months
⁦-19.64%⁩
Last Year
⁦+12.13%⁩
EL7 Factor Analysis
How we score this
Overall83
Excellent — top fifth of the marketContrarianF 7/8Better than 83% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
97
4.0x▲17.8xTop tier
▸
Growth
83
2.6%▼7.1%Top tier
▸
Quality
77
——Top tier
▸
Safety
7
——Bottom tier
▸
Capital Return
67
—2.12%Top tier
▸
Momentum
40
31.7%▲2.9%Around median
▸
Sentiment
72
5▲3Top tier
Fair Value
Low confidenceCurrent price$50
Analyst target · 2 analysts
$55
⁦+10%⁩
See it undervalued
Range ⁦$41–$72⁩
vs
DCF (estimate)
N/A (negative FCF)

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener
Premium content

Get Your Premium Account Now

  • Stock Deep Analysis
  • The Advanced News Platform
Recommended
Annual plan
$17/mo
Monthly plan
$29/mo

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target· 2 analysts setting price target
$57.44
⁦+14.6%⁩
Current Price $50.11·Median $55.00
Low
$41.00
High
$72.00
Current price
$50.11
Average target
$57.44
Street summary

Stable Targets with Clear Divergence Among Analysts

The average price target has remained unchanged at 57.44 over the past 1, 7, or 30 days. Compared with the current price of 50.84, the average indicates upside of approximately 13%, but the estimates range widely between 41 and 72, reflecting a high degree of divergence in views. The number of analysts included also increased from one to two over the past 7 days without any change in the average, broadening the coverage base without altering the overall direction.

As of 2026-09-10
Revisions momentum · 30d
⁦0.0%⁩
Average rating
★ 2.71
Hold
Analyst coverage
7
Buy conviction
0%
Target dispersion
62%
Wide
Analyst ratings over time7 analysts rating
6
1
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months2.78 → 2.71
Recent analyst moves
  • = Reiterate2026-01-08
    Barclays
    —· $65.00
  • = Reiterate2025-11-06
    Morgan Stanley
    —· $70.00
  • = Reiterate2025-10-09
    Evercore ISI Group
    —· $55.00
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    4.02x
    3.16x25.26x
    Very cheap
  • Forward P/E
    2.56x
    2.76x22.06x
    Very cheap
  • EV / EBITDA
    —
    —
  • FCF Yield
    —
    —
  • Revenue Growth YoY
    2.6%
    -36.3%104.2%
    Below average
  • EPS Growth YoY
    43.0%
    -99.4%194.2%
    Near median
  • Gross Margin
    —
    —
  • ROIC
    —
    —
  • Net Debt / EBITDA
    —
    —
  • Dividend Yield
    —
    —
  • Payout Ratio
    —
    —
  • Altman Z-Score
    —
    —
Financial Analysis
|

Stock Analysis

AI-generated
Based on 2025-08-08 data

Company Overview

Brighthouse Financial operates in the insurance and savings market, generating business from the sale of annuities and life insurance products and the management of investment portfolios associated with these obligations. Key sales drivers include Shield annuities and fixed annuities, along with its participation in the BlackRock LifePath Paycheck product to reach workplace channel customers. Reported segment results show that the Annuities segment is the primary source of adjusted earnings, while the Life Insurance and Run-off segments posted losses in the available period.

In Q2 fiscal 2026, revenue was $2.11 billion, down 2.4% year over year and below expectations, while earnings per share were $4.45 versus estimates of $4.86. In contrast, net income available to shareholders jumped to $956 million, compared with $60 million in Q2 fiscal 2025; this equates to a calculated net income margin of approximately 45.3% of revenue, but its coincidence with declining revenue and earnings per share falling short of estimates makes the quality of the improvement less clear than the net income figure alone.

Q2 fiscal 2025 provides the latest available breakdown of the segment mix: the Annuities segment generated adjusted earnings of $332 million, while the Life Insurance segment recorded an adjusted loss of $26 million, the Run-off segment recorded a loss of $83 million, and Corporate & Other recorded a loss of $25 million. Consolidated adjusted earnings in that quarter were $198 million, or $3.43 per share, and were approximately $60 million below the average quarterly run rate management had expected. These figures reflect operating profitability's reliance on the strength of the Annuities segment and its ability to offset weak underwriting in the other segments.

What's Driving the Stock

  • Q2 fiscal 2026 results showed an important paradox for the stock: net income available to shareholders rose to $956 million from $60 million a year earlier, but earnings per share of $4.45 remained below analysts' estimates of $4.86.
Earnings callEDGAR filings30-day newsInsider activity

Automated analysis for informational purposes only — not investment advice.

  • Q2 fiscal 2026 revenue declined 2.4% to $2.11 billion and came in below expectations, and news reports published on August 6 and 7, 2026 attributed the disappointing results to lower investment income and weak annuity sales.
  • In Q2 fiscal 2025, annuity sales reached $2.6 billion, up 16% sequentially and 8% year over year, including $1.9 billion from Shield and $500 million from fixed annuities; Shield sales in the first half of fiscal 2025 also reached $3.9 billion.
  • Life insurance generated sales of $33 million in Q2 fiscal 2025, bringing first-half sales to a record $69 million, up approximately 21% from the corresponding period of fiscal 2024, while BlackRock LifePath Paycheck received deposits of $176 million during the quarter.
  • The capital position remained pivotal in Q2 fiscal 2025, with the combined risk-based capital ratio ranging between 405% and 425%, within the target range of 400% to 450%, and total adjusted capital of approximately $5.6 billion, with liquidity exceeding $900 million at the holding company.
  • Buying & Selling Case

    ▲ Buying Case4 pts

    • +The jump in net income available to shareholders to $956 million in Q2 fiscal 2026, from $60 million a year earlier, provides evidence that reported results can improve sharply even while revenue and earnings per share remain below expectations.
    • +The annuity business has a large and diversified sales base; in Q2 fiscal 2025, sales included $1.9 billion from Shield and $500 million from fixed annuities, with total annuity sales reaching $2.6 billion.
    • +BlackRock LifePath Paycheck expands distribution into the workplace channel, and Brighthouse Financial received deposits of $176 million through the product in Q2 fiscal 2025, alongside first-half life insurance sales growth of approximately 21%.
    • +The capital position provides an important operating buffer; the risk-based capital ratio remained between 405% and 425% in Q2 fiscal 2025, and total adjusted capital increased to approximately $5.6 billion, with holding company liquidity exceeding $900 million.

    ▼ Selling Case6 pts

    • −Q2 fiscal 2026 results faced clear operating pressure, as revenue declined 2.4% to $2.11 billion and earnings per share of $4.45 came in below analysts' estimates of $4.86, with lower investment income and weak annuity sales cited.
    • −Earnings are highly sensitive to alternative investment returns; in Q2 fiscal 2025, the alternative portfolio return was only 1.5%, versus a long-term expectation of between 9% and 11% annually, reducing alternative investment income by $32 million relative to the expected average quarterly run rate.
    • −The company bears meaningful underwriting and mortality risks; claims severity in Q2 fiscal 2025 was approximately 18% above the normal level, and a lower underwriting margin contributed to an adjusted loss of $26 million in the Life Insurance segment and $83 million in the Run-off segment.
    • −Segment earnings depend heavily on Annuities, which generated $332 million in adjusted earnings in Q2 fiscal 2025, while the other three segments recorded combined adjusted losses of $134 million; therefore, any sustained weakness in annuity sales or fees could have a disproportionate impact on profitability.
    • −Management acknowledged in the August 8, 2025 call that competition is widespread in the Shield market and that growth has become more difficult from a large base, while Shield sales of $3.9 billion in the first half of fiscal 2025 were only flat compared with the same period of the prior year, despite total annuity sales reaching strong levels.
    • −Valuation remains subject to wide variation in analysts' estimates, with targets ranging from $41 to $72 and a consensus Neutral rating; trailing twelve-month earnings per share in fiscal 2026 data are also negative at approximately $1.13, making the traditional price-to-earnings multiple unsuitable as a stable valuation anchor.

    Valuation

    The average analyst price target is $57.44 within a wide range of $41 to $72, versus a Neutral consensus; the average is approximately 14% below the 52-week range high of $66.80, while the highest target exceeds that high by approximately 7.8%. Although an August 6, 2026 news report cited a price-to-earnings multiple of 4.88 times, fiscal 2026 EDGAR data show negative trailing twelve-month earnings per share of approximately $1.13, so that multiple and the wide gap between the lowest and highest targets should be treated with caution.

    HoldAnalyst target: $57.44(+14.6%)

    Figures in the text are as of 2026-08-31; the live price is shown at the top of the page.

    FAQ

    Why did BHF's results miss expectations in Q2 fiscal 2026?

    Earnings per share were $4.45 versus analysts' estimates of $4.86, while revenue of $2.11 billion also came in below expectations. Revenue declined 2.4% from Q2 fiscal 2025, and news reports on August 6 and 7, 2026 pointed to lower investment income and weak annuity sales. At the same time, net income available to shareholders rose to $956 million from $60 million, making the quarterly picture mixed rather than entirely negative.

    How important is the Shield product to Brighthouse Financial's business?

    Shield was the largest contributor to annuity sales during Q2 fiscal 2025, generating $1.9 billion of the $2.6 billion total. Its sales in the first half of fiscal 2025 reached $3.9 billion, in line with the same period of fiscal 2024. However, management explained in the August 8, 2025 call that competition remains and that growth from a large base has become more difficult, while continuing to maintain pricing discipline.

    Is BHF's capital position strong?

    The company estimated its combined risk-based capital ratio at between 405% and 425% as of June 30, 2025, within the target range of 400% to 450% under normal market conditions. Total adjusted capital was approximately $5.6 billion, up from approximately $5.5 billion as of March 31, 2025. Liquid assets at the holding company also exceeded $900 million, but the ratio declined sequentially due to the seasonality of capital charges for the fixed business and negative results outside variable annuities.

    What does BlackRock LifePath Paycheck add to BHF's growth story?

    Brighthouse Financial received deposits of $176 million through BlackRock LifePath Paycheck in Q2 fiscal 2025. Management believes the product provides access to new customers through the workplace channel, adding a distribution path distinct from traditional annuity channels. These deposits coincided with quarterly life insurance sales of $33 million and record first-half sales of $69 million.

    Why do Brighthouse Financial's earnings fluctuate from quarter to quarter?

    Results are linked to alternative investment returns, underwriting margins, and movements in annuity reserves and hedges. In Q2 fiscal 2025, the alternative investment portfolio return was only 1.5%, reducing income by approximately $32 million relative to the expected average quarterly run rate, while mortality claims severity was approximately 18% above normal. As a result, adjusted earnings were $198 million, approximately $60 million below the average quarterly run rate management had expected.

    How do analysts view BHF's stock valuation?

    The consensus rating is Neutral, and the average price target is $57.44, with a low target of $41 and a high target of $72. The average is below the 52-week range high of $66.80, while the highest target exceeds that high. Trailing twelve-month earnings per share in fiscal 2026 data are also negative at approximately $1.13, so the traditional price-to-earnings multiple does not provide a stable reference on its own.